Next Level Private
LRMR icon

Next Level Private’s Larimar Therapeutics LRMR Stock Holding History

Next Level Private’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$133K Hold
41,700
– – 0.03% 187
2026
Q2 		$127K Hold
41,700
– – 0.02% 173
2026
Q1 		$188K Hold
41,700
– – 0.04% 174
2025
Q4 		$159K Hold
41,700
– – 0.04% 160
2025
Q3 		$201K Buy
41,700
+21,700
+109% +$81.4K 0.06% 154
2025
Q2 		$57.8K Buy
+20,000
New +$46.3K 0.02% 149

Other funds holding LRMR

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Next Level Private's LRMR Position: Q3 2026 in Review

Next Level Private held its Larimar Therapeutics (LRMR) position steady in Q3 2026 at 41,700 shares worth $133K. The position accounts for 0.03% of the portfolio, ranked #187.

Next Level Private first reported a position in LRMR in Q2 2025 and has held it in 6 quarters since. The position peaked at $201K in Q3 2025. 47 funds tracked by Wall St. Rank hold LRMR as of Q3 2026.

  • Next Level Private held 41,700 shares of Larimar Therapeutics worth $133K as of Q3 2026.
  • Next Level Private left its Larimar Therapeutics share count unchanged in Q3 2026.
  • Larimar Therapeutics made up 0.03% of Next Level Private's portfolio in Q3 2026, its #187 holding.
  • Next Level Private first reported a position in Larimar Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • Next Level Private's Larimar Therapeutics position peaked at $201K in Q3 2025.
  • 47 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2026.

Based on Next Level Private's 13F filing for Q3 2026, filed 20 Oct 2026.